How much funding has Ataraxis raised?

Ataraxis has raised $24.4M in total funding, most recently a Series A round.

Who are Ataraxis's investors?

Ataraxis's investors include Giant Ventures, Obvious Ventures, AIX Ventures, Founders Fund, Floating Point Ventures, Bertelsmann Investment.

Where is Ataraxis headquartered?

Ataraxis is headquartered in New York, New York, United States.

What industry is Ataraxis in?

Ataraxis operates in Artificial Intelligence, Healthcare, Biotech.

Ataraxis

formerly Ataraxis AI

Transforming Cancer Care with AI Precision Medicine

New York, United States · Founded 2022 · $24.4M raised

Artificial Intelligence

Healthcare

Biotech

Headquarters: New York, New York
Employees: 11–50
Founded: 2022
Business Model: B2B

Website: ataraxis.ai
Total Funding: $24.4M
Last Round: $20.4M Series AMar 2025
Rounds: 2

About

Ataraxis AI is an AI precision medicine company building foundation models for oncology that empower physicians to personalize cancer treatment. Their flagship product, Ataraxis Breast, is the first clinically available AI-native breast cancer platform that analyzes multi-modal patient data to predict outcomes and guide treatment selection, reducing unnecessary chemotherapy.

Summary

Ataraxis is an Artificial Intelligence company based in New York, United States, founded in 2022. It has raised $24.4M in total across 2 rounds, most recently a $20.4M Series A round in Mar 2025. Investors include Giant Ventures, Obvious Ventures and AIX Ventures.

LinkedIn X (Twitter)